Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OMEROS CORPOMER · Entity 4756 | Director · Chairman, CEO & President | July 22, 2026 | July 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OMEROS CORP
Report date July 22, 2026 · Filed July 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.84 · Expires 2036-07-22 | Direct | 1,000,000 |
Reported balance
After 2026-07-22 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-22 · Grant · Acquired 1,000,000 · Balance 1,000,000 F1: One-third of the total number of shares subject to the option will vest and become exercisable on August 1, 2027. The remaining shares shall vest in 32 equal monthly installments on the first day of each month thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: One-third of the total number of shares subject to the option will vest and become exercisable on August 1, 2027. The remaining shares shall vest in 32 equal monthly installments on the first day of each month thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2026 Filed Jul 25, 2026 01:17 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (right to buy) · Derivative | 1,000,000 | $0.00 Strike: $9.84 | $0.00 |
DisclosureSEC source: 0001437749-26-024443 · rdgdoc.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000,000 Underlying: Common Stock · 1,000,000 shares Expires 2036-07-22 F1 · derivative.exercise_date: One-third of the total number of shares subject to the option will vest and become exercisable on August 1, 2027. The remaining shares shall vest in 32 equal monthly installments on the first day of each month thereafter. Read SEC document |
| February 18, 2026 Filed Feb 21, 2026 02:40 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock option (right to buy) · Derivative | 400,000 | $0.00 Strike: $10.27 | $0.00 |
DisclosureSEC source: 0001437749-26-004950 · rdgdoc.xml · derivative · entry 6 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 400,000 shares Expires 2026-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option vested and became exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2015. Read SEC document |
| February 18, 2026 Filed Feb 21, 2026 02:40 UTC | OMEROS CORP OMER · Entity 4756 | Tax withholdingCommon stock | 357,678 | $11.93 | $4,267,098.54 |
DisclosureSEC source: 0001437749-26-004950 · rdgdoc.xml · nonDerivative · entry 2 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,469,308 F1 · shares: Represents shares withheld by Omeros Corporation ("Omeros") in connection with net share settlement to satisfy the exercise price and tax liability associated with the reporting person's exercise of stock options. The number of shares withheld was determined based on the closing price of Omeros' common stock on February 17, 2026. The transaction did not involve any open-market sale of securities, and all 357,678 withheld shares remained in the Omeros treasury. Read SEC document |
| February 18, 2026 Filed Feb 21, 2026 02:40 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon stock | 400,000 | $10.27 | $4,108,000.00 |
DisclosureSEC source: 0001437749-26-004950 · rdgdoc.xml · nonDerivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,826,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 23:16 UTC | OMEROS CORP OMER · Entity 4756 | GiftCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-031087 · rdgdoc.xml · nonDerivative · entry 3 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: No plan indicated Ownership: Indirect · By trust Disclosed balance after: 300,000 F1 · kind: The reporting person made bona fide gifts of Omeros Corporation common stock, each of 300,000 shares, to separate irrevocable trusts established for the benefit of each of the reporting person's two minor children. F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and nothing in this report shall be deemed an admission that the reporting person is the beneficial owner of such securities under Section 16 of the Securities Exchange Act of 1934 or for any other purpose. F4 · ownership.nature: Shares held in the [Demopulos Child #2] Gift Trust, an irrevocable trust established for the benefit of a minor child of the reporting person. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 23:16 UTC | OMEROS CORP OMER · Entity 4756 | GiftCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-031087 · rdgdoc.xml · nonDerivative · entry 2 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: No plan indicated Ownership: Indirect · By trust Disclosed balance after: 300,000 F1 · kind: The reporting person made bona fide gifts of Omeros Corporation common stock, each of 300,000 shares, to separate irrevocable trusts established for the benefit of each of the reporting person's two minor children. F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and nothing in this report shall be deemed an admission that the reporting person is the beneficial owner of such securities under Section 16 of the Securities Exchange Act of 1934 or for any other purpose. F3 · ownership.nature: Shares held in the [Demopulos Child #1] Gift Trust, an irrevocable trust established for the benefit of a minor child of the reporting person. Read SEC document |
| October 13, 2025 Filed Oct 15, 2025 23:16 UTC | OMEROS CORP OMER · Entity 4756 | GiftCommon Stock | 600,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-031087 · rdgdoc.xml · nonDerivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,426,986 F1 · kind: The reporting person made bona fide gifts of Omeros Corporation common stock, each of 300,000 shares, to separate irrevocable trusts established for the benefit of each of the reporting person's two minor children. Read SEC document |
| June 30, 2025 Filed Jul 1, 2025 21:32 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (right to buy) · Derivative | 865,000 | $0.00 Strike: $3.20 | $0.00 |
DisclosureSEC source: 0001437749-25-021814 · rdgdoc.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 865,000 Underlying: Common Stock · 865,000 shares Expires 2035-06-30 F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2025. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| April 25, 2024 Filed Apr 29, 2024 21:12 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (right to buy) · Derivative | 725,000 | $0.00 Strike: $3.06 | $0.00 |
DisclosureSEC source: 0001437749-24-013751 · rdgdoc.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 725,000 Underlying: Common Stock · 725,000 shares Expires 2034-04-25 F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2024. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| November 17, 2023 Filed Nov 22, 2023 01:11 UTC | OMEROS CORP OMER · Entity 4756 | PurchaseCommon Stock | 15,000 | $1.68 | $25,200.00 |
DisclosureSEC source: 0001437749-23-032809 · rdgdoc.xml · nonDerivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Chairman, CEO & President 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 123,945 F1 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and nothing in this report shall be deemed an admission that the reporting person is the beneficial owner of such securities under Section 16 of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
| November 14, 2023 Filed Nov 16, 2023 02:55 UTC | OMEROS CORP OMER · Entity 4756 | GrantCommon Stock | 25,000 | $1.44 | $36,000.00 |
DisclosureSEC source: 0001437749-23-032239 · rdgdoc.xml · nonDerivative · entry 2 Demopulos Gregory A MD · CIK 0001472160 · Chairman, CEO & President 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 108,945 F3 · price: This transaction was executed in multiple trades at prices ranging from $1.43 to $1.45. The price reported above reflects the weighted average sales price.The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in thisfootnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F4 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and nothing in this report shall be deemed an admission that the reporting person is the beneficial owner of such securities under Section 16 of the Securities Exchange Act of 1934 or for any other purpose. Read SEC document |
| November 13, 2023 Filed Nov 16, 2023 02:55 UTC | OMEROS CORP OMER · Entity 4756 | GrantCommon Stock | 37,500 | $1.29 | $48,375.00 |
DisclosureSEC source: 0001437749-23-032239 · rdgdoc.xml · nonDerivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Chairman, CEO & President 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 83,945 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.26 to $1.30. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. F2 · balance_after: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and nothing in this report shall be deemed an admission that the reporting person is the beneficial owner of such securities under Section 16 of the Securities Exchange Act of 1934 or for any other purpose. The shares reported herein include shares held by the reporting person's spouse with respect to which it was previously determined that the reporting person did not have an indirect pecuniary interest. Read SEC document |
| September 22, 2023 Filed Sep 27, 2023 21:02 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (right to buy) · Derivative | 715,000 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001437749-23-026945 · rdgdoc.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Chairman, CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 715,000 Underlying: Common Stock · 715,000 shares Expires 2033-09-22 F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2023. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| September 21, 2022 Filed Sep 24, 2022 00:26 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (right to buy) · Derivative | 650,000 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001415889-22-009928 · form4-09232022_050901.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,000 Underlying: Common Stock · 650,000 shares Expires 2032-09-21 F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2022. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 01:00 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (right to buy) · Derivative | 550,000 | $0.00 Strike: $14.99 | $0.00 |
DisclosureSEC source: 0001415889-21-003527 · form4-07062021_090702.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,000 Underlying: Common Stock · 550,000 shares Expires 2031-07-01 F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2021. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| June 17, 2021 Filed Jun 18, 2021 00:30 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (right to buy) · Derivative | 36,857 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001415889-21-003077 · form4-06172021_080601.xml · derivative · entry 6 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,857 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| June 17, 2021 Filed Jun 18, 2021 00:30 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 36,857 | $14.90 | $549,169.30 |
DisclosureSEC source: 0001415889-21-003077 · form4-06172021_080601.xml · nonDerivative · entry 4 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,986 F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2020 for expiring options. The trading schedule, including sale dates and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · price: This transaction was executed in multiple trades at prices ranging from $14.72 to $15.06; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| June 17, 2021 Filed Jun 18, 2021 00:30 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 36,857 | $4.10 | $151,113.70 |
DisclosureSEC source: 0001415889-21-003077 · form4-06172021_080601.xml · nonDerivative · entry 3 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,063,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 00:30 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (right to buy) · Derivative | 36,856 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001415889-21-003077 · form4-06172021_080601.xml · derivative · entry 5 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,857 Underlying: Common Stock · 36,856 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 00:30 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 36,856 | $15.02 | $553,577.12 |
DisclosureSEC source: 0001415889-21-003077 · form4-06172021_080601.xml · nonDerivative · entry 2 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,986 F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2020 for expiring options. The trading schedule, including sale dates and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.83 to $15.45; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 00:30 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 36,856 | $4.10 | $151,109.60 |
DisclosureSEC source: 0001415889-21-003077 · form4-06172021_080601.xml · nonDerivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,063,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 21, 2021 22:45 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (right to buy) · Derivative | 36,856 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001415889-21-002642 · form4-05212021_060501.xml · derivative · entry 6 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,713 Underlying: Common Stock · 36,856 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| May 20, 2021 Filed May 21, 2021 22:45 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 36,856 | $14.96 | $551,365.76 |
DisclosureSEC source: 0001415889-21-002642 · form4-05212021_060501.xml · nonDerivative · entry 4 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,986 F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2020 for expiring options. The trading schedule, including sale dates and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · price: This transaction was executed in multiple trades at prices ranging from $13.87 to $15.27; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| May 20, 2021 Filed May 21, 2021 22:45 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 36,856 | $4.10 | $151,109.60 |
DisclosureSEC source: 0001415889-21-002642 · form4-05212021_060501.xml · nonDerivative · entry 3 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,063,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 21, 2021 22:45 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (right to buy) · Derivative | 36,857 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001415889-21-002642 · form4-05212021_060501.xml · derivative · entry 5 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,569 Underlying: Common Stock · 36,857 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| May 19, 2021 Filed May 21, 2021 22:45 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 36,857 | $17.07 | $629,148.99 |
DisclosureSEC source: 0001415889-21-002642 · form4-05212021_060501.xml · nonDerivative · entry 2 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,986 F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2020 for expiring options. The trading schedule, including sale dates and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.92 to $17.60; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| May 19, 2021 Filed May 21, 2021 22:45 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 36,857 | $4.10 | $151,113.70 |
DisclosureSEC source: 0001415889-21-002642 · form4-05212021_060501.xml · nonDerivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,063,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2021 Filed Apr 8, 2021 23:52 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (right to buy) · Derivative | 35,206 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001415889-21-001949 · form4-04082021_040405.xml · derivative · entry 6 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,426 Underlying: Common Stock · 35,206 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| April 08, 2021 Filed Apr 8, 2021 23:52 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 35,206 | $17.76 | $625,258.56 |
DisclosureSEC source: 0001415889-21-001949 · form4-04082021_040405.xml · nonDerivative · entry 4 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,986 F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person for expiring options. The trading schedule, including sale periods and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · price: This transaction was executed in multiple trades at prices ranging from $17.60 to $17.96; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 08, 2021 Filed Apr 8, 2021 23:52 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 35,206 | $4.10 | $144,344.60 |
DisclosureSEC source: 0001415889-21-001949 · form4-04082021_040405.xml · nonDerivative · entry 3 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,062,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2021 Filed Apr 8, 2021 23:52 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (right to buy) · Derivative | 37,407 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001415889-21-001949 · form4-04082021_040405.xml · derivative · entry 5 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,632 Underlying: Common Stock · 37,407 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| April 07, 2021 Filed Apr 8, 2021 23:52 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 37,407 | $17.91 | $669,959.37 |
DisclosureSEC source: 0001415889-21-001949 · form4-04082021_040405.xml · nonDerivative · entry 2 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,986 F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person for expiring options. The trading schedule, including sale periods and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: This transaction was executed in multiple trades at prices ranging from $17.53 to $18.27; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 07, 2021 Filed Apr 8, 2021 23:52 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 37,407 | $4.10 | $153,368.70 |
DisclosureSEC source: 0001415889-21-001949 · form4-04082021_040405.xml · nonDerivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,064,393 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2020 Filed Mar 4, 2020 02:04 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (right to buy) · Derivative | 450,000 | $0.00 Strike: $11.91 | $0.00 |
DisclosureSEC source: 0001415889-20-000612 · form4-03032020_060306.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · CHIARMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2030-02-28 F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of March 1, 2020. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 01:53 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (right to buy) · Derivative | 425,000 | $0.00 Strike: $13.45 | $0.00 |
DisclosureSEC source: 0000899243-19-003364 · doc4.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,000 Underlying: Common Stock · 425,000 shares Expires 2029-02-07 F1 · derivative.exercise_date: This option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of February 8, 2019. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| April 08, 2018 Filed Apr 11, 2018 22:00 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 350,000 | $0.00 Strike: $13.58 | $0.00 |
DisclosureSEC source: 0000899243-18-010008 · doc4.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,000 Underlying: Common Stock · 350,000 shares Expires 2028-04-07 F1 · derivative.exercise_date: The option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2018. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| December 28, 2017 Filed Dec 28, 2017 23:45 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 39,961 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0000899243-17-029690 · doc4.xml · derivative · entry 4 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,039 Underlying: Common Stock · 39,961 shares Expires 2022-01-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On December 28, 2017, the reporting person paid the exercise price and exercised incentive stock options to purchase 39,961 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. This option vested and became exercisable in 48 equal monthly installments. The first installment became exercisable on April 1, 2011 and subsequent installments became exercisable on each monthly anniversary thereafter. Read SEC document |
| December 28, 2017 Filed Dec 28, 2017 23:45 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 102,040 | $0.00 Strike: $2.45 | $0.00 |
DisclosureSEC source: 0000899243-17-029690 · doc4.xml · derivative · entry 3 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 102,040 shares Expires 2017-12-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: On December 28, 2017, the reporting person paid the exercise price and exercised expiring non-qualified stock options to purchase 102,040 shares of the company's common stock. These shares have not been sold and are held for the account of the reporting person. One-fourth of the shares subject to this option vested on December 30, 2008, which was the first anniversary of the grant date, and the remainder became exercisable in equal monthly installments over the following 48 months. In addition to paying the exercise price of the expiring non-qualified stock options, the reporting person is concurrently paying ordinary income taxes incurred as a result of the exercise of these options. Read SEC document |
| December 28, 2017 Filed Dec 28, 2017 23:45 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 39,961 | $4.10 | $163,840.10 |
DisclosureSEC source: 0000899243-17-029690 · doc4.xml · nonDerivative · entry 2 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,986 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2017 Filed Dec 28, 2017 23:45 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 102,040 | $2.45 | $249,998.00 |
DisclosureSEC source: 0000899243-17-029690 · doc4.xml · nonDerivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2017 Filed Mar 1, 2017 01:00 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 375,000 | $0.00 Strike: $11.55 | $0.00 |
DisclosureSEC source: 0000899243-17-005674 · doc4.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,000 Underlying: Common Stock · 375,000 shares Expires 2027-02-25 F1 · derivative.exercise_date: The option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of February 26, 2017. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| December 07, 2016 Filed Dec 8, 2016 02:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 102,044 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0000899243-16-035087 · doc4.xml · derivative · entry 10 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 102,044 shares Expires 2016-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested and became exercisable in 48 equal monthly installments. The first installment became exercisable on March 28, 2005 and subsequent installments became exercisable on each monthly anniversary thereafter. Read SEC document |
| December 07, 2016 Filed Dec 8, 2016 02:00 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 102,044 | $10.48 | $1,069,033.35 |
DisclosureSEC source: 0000899243-16-035087 · doc4.xml · nonDerivative · entry 6 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,884,985 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted earlier this year by the reporting person that provides for the exercise and sale of options to purchase 612,244 shares of common stock that expire on December 11, 2016 and 100 shares of common stock that expire on April 7, 2020; the latter at a threshold price of $100.00 per share. Under the plan, the options expiring on December 11, 2016, which do not provide for an extension of the exercise period, would be exercised and sold during fixed sale periods at specified prices and numbers in each sale period. The 306,124 shares of common stock sold during this reporting period complete the sale of all shares associated with the options expiring on December 11, 2016. Consistent with the applicable trading rules, the reporting person has had no further control over the terms or timing of sales under the plan. F2 · kind: (Continued from Footnote 1) A portion of the proceeds from the exercise of the options expiring on December 11, 2016, all of which are non-qualified, are being used to fund in part the reporting person's exercise of all incentive stock options that otherwise would expire on December 11, 2016. F5 · price: This transaction was executed in multiple trades at prices ranging from $10.26 to $10.78; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| December 07, 2016 Filed Dec 8, 2016 02:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 102,044 | $0.98 | $100,003.12 |
DisclosureSEC source: 0000899243-16-035087 · doc4.xml · nonDerivative · entry 5 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987,029 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 02:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 102,040 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0000899243-16-035087 · doc4.xml · derivative · entry 9 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,044 Underlying: Common Stock · 102,040 shares Expires 2016-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested and became exercisable in 48 equal monthly installments. The first installment became exercisable on March 28, 2005 and subsequent installments became exercisable on each monthly anniversary thereafter. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 02:00 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 102,040 | $10.80 | $1,101,807.51 |
DisclosureSEC source: 0000899243-16-035087 · doc4.xml · nonDerivative · entry 4 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,884,985 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted earlier this year by the reporting person that provides for the exercise and sale of options to purchase 612,244 shares of common stock that expire on December 11, 2016 and 100 shares of common stock that expire on April 7, 2020; the latter at a threshold price of $100.00 per share. Under the plan, the options expiring on December 11, 2016, which do not provide for an extension of the exercise period, would be exercised and sold during fixed sale periods at specified prices and numbers in each sale period. The 306,124 shares of common stock sold during this reporting period complete the sale of all shares associated with the options expiring on December 11, 2016. Consistent with the applicable trading rules, the reporting person has had no further control over the terms or timing of sales under the plan. F2 · kind: (Continued from Footnote 1) A portion of the proceeds from the exercise of the options expiring on December 11, 2016, all of which are non-qualified, are being used to fund in part the reporting person's exercise of all incentive stock options that otherwise would expire on December 11, 2016. F4 · price: This transaction was executed in multiple trades at prices ranging from $10.45 to $11.13; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 02:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionCommon Stock | 102,040 | $0.98 | $99,999.20 |
DisclosureSEC source: 0000899243-16-035087 · doc4.xml · nonDerivative · entry 3 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2016 Filed Dec 8, 2016 02:00 UTC | OMEROS CORP OMER · Entity 4756 | GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $10.56 | $0.00 |
DisclosureSEC source: 0000899243-16-035087 · doc4.xml · derivative · entry 8 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2026-12-04 F7 · derivative.exercise_date: The option vests and becomes exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2016. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| December 05, 2016 Filed Dec 8, 2016 02:00 UTC | OMEROS CORP OMER · Entity 4756 | Exercise / conversionStock Option (Right to Buy) · Derivative | 102,040 | $0.00 Strike: $0.98 | $0.00 |
DisclosureSEC source: 0000899243-16-035087 · doc4.xml · derivative · entry 7 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,084 Underlying: Common Stock · 102,040 shares Expires 2016-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vested and became exercisable in 48 equal monthly installments. The first installment became exercisable on March 28, 2005 and subsequent installments became exercisable on each monthly anniversary thereafter. Read SEC document |
| December 05, 2016 Filed Dec 8, 2016 02:00 UTC | OMEROS CORP OMER · Entity 4756 | SaleCommon Stock | 102,040 | $10.71 | $1,092,644.32 |
DisclosureSEC source: 0000899243-16-035087 · doc4.xml · nonDerivative · entry 2 Demopulos Gregory A MD · CIK 0001472160 · Director · Chairman, CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,884,985 F1 · kind: Open market sale pursuant to a Rule 10b5-1 trading plan adopted earlier this year by the reporting person that provides for the exercise and sale of options to purchase 612,244 shares of common stock that expire on December 11, 2016 and 100 shares of common stock that expire on April 7, 2020; the latter at a threshold price of $100.00 per share. Under the plan, the options expiring on December 11, 2016, which do not provide for an extension of the exercise period, would be exercised and sold during fixed sale periods at specified prices and numbers in each sale period. The 306,124 shares of common stock sold during this reporting period complete the sale of all shares associated with the options expiring on December 11, 2016. Consistent with the applicable trading rules, the reporting person has had no further control over the terms or timing of sales under the plan. F2 · kind: (Continued from Footnote 1) A portion of the proceeds from the exercise of the options expiring on December 11, 2016, all of which are non-qualified, are being used to fund in part the reporting person's exercise of all incentive stock options that otherwise would expire on December 11, 2016. F3 · price: This transaction was executed in multiple trades at prices ranging from $10.49 to $11.15; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.